National Health Investors Q1 2024 FFO $1.12 Beats $1.06 Estimate, Sales $81.513M Beat $76.851M Estimate
Portfolio Pulse from Benzinga Newsdesk
National Health Investors (NHI) reported Q1 2024 FFO of $1.12 per share, surpassing the $1.06 estimate, with sales of $81.513M also beating the $76.851M estimate, despite a 1.06% decrease from the previous year.
May 06, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
National Health Investors reported a strong Q1 2024 with FFO and sales exceeding estimates, indicating robust financial health despite a slight year-over-year sales decline.
Beating both FFO and sales estimates suggests NHI is performing well financially, which could positively influence investor sentiment and potentially drive up the stock price in the short term. The slight decrease in year-over-year sales might be a concern, but the overall positive earnings report is likely to have a more significant impact on investor perception.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100